BPC-157 Research
BPC-157 is a synthetic 15-amino-acid peptide derived from a partial fragment of a protein found in gastric juice, studied extensively in laboratory models for its effects on angiogenesis, connective-tissue organization, and the gastrointestinal tract. Distributed strictly as a research chemical.
Also known as: Stable Gastric Pentadecapeptide BPC 157 · PL 14736
In experimental and cell-culture studies, BPC-157 has been associated with upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) signaling and modulation of the nitric oxide (NO) system, both implicated in new blood-vessel formation. Research models also report interaction with growth-factor and focal-adhesion pathways that govern fibroblast migration and extracellular-matrix assembly.
Mechanism of Action
Published research literature characterizes BPC-157 primarily through its apparent influence on angiogenic signaling. In experimental and in-vitro endothelial systems, researchers have reported increased expression and activation of VEGFR2, a receptor central to capillary sprouting, alongside engagement of the nitric oxide pathway that regulates vascular tone and endothelial behavior. Additional reports describe modulation of growth-factor receptor activity and focal-adhesion kinase signaling, which together coordinate fibroblast migration and collagen deposition. The peptide is also noted for stability in gastric environments under laboratory conditions. These observations derive entirely from experimental models and cultured cells and are presented for scientific reference, not as evidence of any effect in humans.
Research Applications
BPC-157 is most frequently examined in laboratory studies of connective-tissue and gastrointestinal biology. Reported research areas include tendon, ligament, and muscle fibroblast behavior in cell culture; experimentally induced mucosal lesion models in experimental systems; and vascular network formation assays. Investigators have also used it as a tool compound to probe VEGFR2/NO signaling and angiogenesis-dependent processes. Because it appears stable in acidic media, some laboratory protocols evaluate it across both injectable and oral administration routes in experimental systems. This material is supplied for in-vitro and experimental-model experimentation only and is not intended for human or veterinary administration.
Handling & Research Considerations
As a lyophilized peptide, BPC-157 is typically prepared with bacteriostatic or sterile water for laboratory preparation and stored frozen prior to use, with prepared aliquots kept refrigerated to limit degradation. Researchers commonly verify identity and purity via mass spectrometry and HPLC before experimental work. Because research findings span multiple tissue systems, study designs should specify model type, concentration ranges, and endpoints clearly to support reproducibility. Documented variability across experimental models means results should be interpreted cautiously and not extrapolated beyond the experimental context.
Applications at a glance
- Angiogenesis and VEGFR2/NO signaling research
- Connective-tissue fibroblast and matrix studies in vitro
- Gastrointestinal mucosal lesion models in experimental systems
- Reference compound for growth-factor pathway investigation